These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31715077)

  • 1. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.
    Ahmed A; Williams DJ; Cheed V; Middleton LJ; Ahmad S; Wang K; Vince AT; Hewett P; Spencer K; Khan KS; Daniels JP;
    BJOG; 2020 Mar; 127(4):478-488. PubMed ID: 31715077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial.
    Cluver CA; Hiscock R; Decloedt EH; Hall DR; Schell S; Mol BW; Brownfoot F; Kaitu'u-Lino TJ; Walker SP; Tong S
    BMJ; 2021 Sep; 374():n2103. PubMed ID: 34551918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study.
    Peguero A; Fernandez-Blanco L; Mazarico E; Benitez L; Gonzalez A; Youssef L; Crispi F; Hernandez S; Figueras F
    BJOG; 2021 Jan; 128(2):158-165. PubMed ID: 32593222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.
    Ngene NC; Moodley J; Naicker T
    PLoS One; 2019; 14(4):e0215807. PubMed ID: 31022243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia.
    Döbert M; Varouxaki AN; Mu AC; Syngelaki A; Ciobanu A; Akolekar R; De Paco Matallana C; Cicero S; Greco E; Singh M; Janga D; Del Mar Gil M; Jani JC; Bartha JL; Maclagan K; Wright D; Nicolaides KH
    Circulation; 2021 Aug; 144(9):670-679. PubMed ID: 34162218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol.
    Cluver CA; Walker SP; Mol BW; Theron GB; Hall DR; Hiscock R; Hannan N; Tong S
    BMJ Open; 2015 Oct; 5(10):e008211. PubMed ID: 26510725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia.
    Costantine MM; West H; Wisner KL; Caritis S; Clark S; Venkataramanan R; Stika CS; Rytting E; Wang X; Ahmed MS;
    Am J Obstet Gynecol; 2021 Dec; 225(6):666.e1-666.e15. PubMed ID: 34033812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
    Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol.
    Langston-Cox AG; Marshall SA; Palmer KR; Wallace EM
    BMJ Open; 2019 Oct; 9(10):e027493. PubMed ID: 31628121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.
    Rayman MP; Searle E; Kelly L; Johnsen S; Bodman-Smith K; Bath SC; Mao J; Redman CW
    Br J Nutr; 2014 Jul; 112(1):99-111. PubMed ID: 24708917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
    Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
    Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin.
    Navaratnam K; Abreu P; Clarke H; Jorgensen A; Alfirevic A; Alfirevic Z
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):179-187. PubMed ID: 28851242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study.
    Barjaktarovic M; Korevaar TIM; Jaddoe VWV; de Rijke YB; Peeters RP; Steegers EAP
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):477-483. PubMed ID: 30834627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.
    Thadhani R; Hagmann H; Schaarschmidt W; Roth B; Cingoez T; Karumanchi SA; Wenger J; Lucchesi KJ; Tamez H; Lindner T; Fridman A; Thome U; Kribs A; Danner M; Hamacher S; Mallmann P; Stepan H; Benzing T
    J Am Soc Nephrol; 2016 Mar; 27(3):903-13. PubMed ID: 26405111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.